Literature DB >> 22382308

Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.

Loïc Fin1, Joël Daouk, Pascal Bailly, Jérôme Slama, Julie Morvan, Isabelle El Esper, Jean-Marc Régimbeau, Denis Chatelain, Momar Diouf, Marc-Etienne Meyer.   

Abstract

BACKGROUND: In 18F-fluorodeoxyglucose PET/CT, respiratory motion induces bias in image interpretations (i.e. organ misregistration or lesion omission/underestimation).
OBJECTIVE: The present study applied our custom gating method (referred to as 'CT-based gated PET' and that has already been validated by our research group) to PET imaging of the liver and compared its per lesion sensitivity with that of standard clinical (i.e. ungated) PET.
METHODS: A total of 13 patients scheduled for liver surgery were referred to our department for PET/CT imaging. Each patient underwent both ungated and CT-based gated PET imaging protocols. Two independent, blinded observers interpreted the two sets of PET images and reached a consensus when necessary. Image interpretations were combined with histological analysis and/or intraoperative ultrasound examination to compute each method's per lesion sensitivity and true positive fraction. Analyses were also performed by considering lesions according to their size (longest axis over 10 mm or over 15 mm).
RESULTS: Forty-eight lesions were confirmed by pathology reports. When considering all the uptakes, the ungated and the CT-based gated PET methods had sensitivities of 54.2 and 64.6% (P=0.025) and true positive fractions of 83.9 and 86.1%, respectively. When considering uptakes greater than 10 mm in size, ungated and CT-based gated PET had sensitivities of 74.3 and 88.6% (P=0.025), respectively. For lesions greater than 15 mm in size, the corresponding sensitivities were 85.2 and 100% (P=0.046).
CONCLUSION: CT-based gated PET yielded a higher lesion-based sensitivity than routine, ungated PET did. Hence, this method improves the detection of intrahepatic colorectal metastases--especially for lesions that are close in size to the detection limit of the PET gantry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382308     DOI: 10.1097/MNM.0b013e328351fce8

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.

Authors:  Cinzia Crivellaro; Elena De Ponti; Federica Elisei; Sabrina Morzenti; Maria Picchio; Valentino Bettinardi; Annibale Versari; Federica Fioroni; Miroslaw Dziuk; Konrad Tkaczewski; Renée Ahond-Vionnet; Guillaume Nodari; Sergio Todde; Claudio Landoni; Luca Guerra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

2.  Assessing and accounting for the impact of respiratory motion on FDG uptake and viable volume for liver lesions in free-breathing PET using respiration-suspended PET images as reference.

Authors:  Guang Li; C Ross Schmidtlein; Irene A Burger; Carole A Ridge; Stephen B Solomon; John L Humm
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

Review 3.  Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.

Authors:  Russell Frood; Garry McDermott; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 4.  Management of respiratory motion in PET/computed tomography: the state of the art.

Authors:  Audrey Pépin; Joël Daouk; Pascal Bailly; Sébastien Hapdey; Marc-Etienne Meyer
Journal:  Nucl Med Commun       Date:  2014-02       Impact factor: 1.690

Review 5.  MR-PET of the body: Early experience and insights.

Authors:  Miguel Ramalho; Mamdoh AlObaidy; Onofrio A Catalano; Alexander R Guimaraes; Marco Salvatore; Richard C Semelka
Journal:  Eur J Radiol Open       Date:  2014-09-16

6.  Respiratory 4D-Gating F-18 FDG PET/CT Scan for Liver Malignancies: Feasibility in Liver Cancer Patient and Tumor Quantitative Analysis.

Authors:  Anson H Y Cheung; Vincent W C Wu; Andy L Y Cheung; Jing Cai
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.